Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-026666

EVP and Chief Legal Officer sold 3,756 shares at $53.76 ($201,923)

  • EVP and Chief Legal Officer acquired 18,757 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Parschauer Karah Herdman · EVP and Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-01 Grant or award : show line 1 in the form +17,800 69,782 D
2024-03-01 Grant or award : show line 2 in the form +957 70,739 D
2024-03-01 Sale : show line 3 in the form −3,756 $53.76 $201,923 67,340 D
Open-market sales · 3,756 sh · avg $53.76 · $201,923

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 4 in the form Stock Option (Right to Buy) +31,400 31,400 D
Loading xslF345X05/ownership.xml…